Many laboratories are determining the role of vitamin A metabolism in various forms of hair loss, including Central Centrifugal Cicatricial Alopecia (CCCA, follicular degeneration syndrome, hot comb alopecia) and Alopecia Areata. CCCA is a permanent hair loss disease that is seen primarily in African American women. ULBP3 is turned off in normal hair follicles but turned on in alopecia areata follicles. In its activated state, ULBP3 attracts killer immune cells with a special receptor called NKG2D, which triggers an autoimmune attack. Vitiligo itself does not endanger your health, but can be associated with thyroid problems, pernicious anemia, Addison’s disease (decreased adrenal gland function) and alopecia areata (patches of hair loss). For most patients, however, the greatest risk is loss of self-esteem.
The inflammation involved in AA focuses on the roots of hair follicles deep in the skin. As a result there is very little visible at the skin surface. Alopecia areata is a condition in which hair is lost either from part of the scalp, all of the scalp, or the entire body, and it affects 1% to 2% of the population. It is thought to be an autoimmune disease and in some cases the disease is hereditary. In children with only a few patches of hair loss, complete regrowth is seen in 95 % of cases within 1 year. Early onset of hair loss (less than 2 years of age), more extensive hair loss ( totalis or universalis ) and hair loss in bands around the scalp predict a worse prognosis.
Recently, there have been reports from Europe using the 308-nm Excimer Laser to achieve scalp hair regrowth in alopecia areata. We felt that this treatment would offer a safe and painless alternative treatment for patient with eyebrow alopecia areata. Low-level laser and LED treatment for wounds, skin conditions, and alopecia areata will be covered, along with treatment of musculoskeletal conditions, neuropathy, post-herpetic neuralgia and smoking cessation. The course combines relevant research and case studies with practical, hands-on experience. Diffuse thinning of the scalp in alopecia areata which is more commonly seen in women has a very uncertain prognosis, but it has been associated with spontaneous remission. Generalized alopecia areata in which scalp hairs, eyebrows, eyelashes and body hair are lost has a very unfavorable prognosis in that the hair is unlikely to regrow spontaneously.
Substantial evidence indicates that genetic factors may have a role in the etiology of alopecia areata (AA). Most studies, however, provide only general information on the familial incidence but fail to specify family relationships. In conclusion, alopecia areata-like hair loss in C3H/HeJ mice responded to treatment with the contact sensitizer squaric acid dibutylester analogous to human alopecia areata. Moreover, successful treatment changes the aberrant expression of major histocompatibility complex class I and II in a way similar to that observed in human alopecia areata. As confirmation of microarray analysis results, lymph node and spleen cells from alopecia areata affected mice injected into normal haired littermates transferred the alopecia areata phenotype. Alopecia areata onset could be inhibited in skin-grafted mice by modulation with B7.1- and B7.2-specific monoclonal antibodies.
Cytokine expression also increased postsurgery in sham and alopecia areata grafted mice, but remained elevated only in mice receiving alopecia areata affected skin. The present study does not therefore provide evidence of a significant role of emotional stress in the pathogenesis of alopecia areata. The Dundee experimental bald rat (DEBR) undergoes hair loss associated with perifollicular infiltrates of mononuclear cells (MNC), a pathological characteristic of human alopecia areata (AA). To investigate further the pathogenesis of the disease in this animal model, we have studied the development, composition and extent of the perifollicular MNC infiltration in young (6-week-old), prelesional (3-month-old), active lesional, and established lesional DEBR rats, using 6-week- and 6-month-old Wistar rats as normal controls.
A history of the following 14 autoimmune disorders among living first and second-degree relatives was obtained: alopecia areata, ankylosing spondylitis, dermatomyositis, Graves’ disease, Hashimoto’s thyroiditis, IDDM, inflammatory bowel disorder, iritis, JRA, multiple sclerosis, psoriasis, rheumatoid arthritis, SLE and vitiligo. Chi-squares and odds ratios with 95% confidence intervals were calculated.
Want to find out more about alopecia areata treatment, then visit Shawn Everette’s website where you’ll discover proven alopecia areata treatment.